Pellicano R and Fagoonee S |
One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015? |
|
Saudi J Gastroenterol |
pmid:26655127
|
Lin TY et al. |
An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia. |
|
Chang Gung Med J |
pmid:17939262
|
Morimoto S et al. |
Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. |
1984 |
J. Antibiot. |
pmid:6706855
|
Pike VW et al. |
Semi-automated preparation of a 11C-labelled antibiotic--[N-methyl-11C]erythromycin A lactobionate. |
1984 |
Int J Appl Radiat Isot |
pmid:6231252
|
Fernandes PB et al. |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. |
1986 |
Antimicrob. Agents Chemother. |
pmid:2949695
|
Benson CA et al. |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952063
|
Barry AL et al. |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952064
|
Chin NX et al. |
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953303
|
Bowie WR et al. |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953304
|
Floyd-Reising S et al. |
In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2955742
|